Bristol-Myers Hepatitis C Drug Approved in Europe

European regulators have approved a Bristol-Myers Squibb Inc. drug for use in hepatitis C combination treatments, the company said.



from WSJ.com: US Business http://ift.tt/1tJh8sa

via IFTTT